Neuropharmacologic aspects of the ocular motor system and the treatment of abnormal eye movements

Current Opinion in Neurology

Volumn 12, Issue 1, 1999, Pages 21-27

  Leigh, R John ^a,c   Ramat, Stefano ^b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; GABAPENTIN; MEMANTINE; NEUROTRANSMITTER;

EYE MOVEMENT; EYE MOVEMENT DISORDER; GAZE; HUMAN; MOTOR SYSTEM; NEUROPHARMACOLOGY; NONHUMAN; NYSTAGMUS; REVIEW;

NON-PROGRAMMATIC;

ABDUCENS NERVE; ACETIC ACIDS; AMINES; BACLOFEN; CRANIAL NERVE DISEASES; CYCLOHEXANECARBOXYLIC ACIDS; EYE MOVEMENTS; FIXATION, OCULAR; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOGLOSSAL NERVE; OCULAR MOTILITY DISORDERS; VESTIBULAR NERVE; VISUAL PATHWAYS;

EID: 0032979421     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199902000-00004     Document Type: Review

References (31)

1. 1 Brandt T. Vertigo. Its multisensory syndromes, 2nd ed. New York: Springer Verlag; 1998. This book provides an informative review of the vestibular system and its disorders.
2. 2 Leigh RJ, Zee DS. The neurology of eye movements (text/CD), 3rd ed. New York: Oxford University Press; 1998. A comprehensive review of normal and abnormal control of eye movements, with video clips, is provided.
3. 3 McElligot JG, Spencer RF. Neuropharmacological aspects of the vestibuloocular reflex. In: Anderson JH, Beitz AJ (editors). Neurochemistry of the vestibular system. London: CRC A lucid summary of the neuropharmacology of vestibular eye movements.
4. 4 Zhou W, King WM. Premotor commands encode monocular eye movements. Nature 1998; 393:692-695. This provocative report purports to disprove Hering's law of equal innervation of the eyes.
5. 5 Moschovakis AK, Scudder CA, Highstein SM. A structural basis for Hering's law: projections to extraocular motoneurons. Science 1990; 248:1118-1119.
6. 6 Arnold DB, Robinson DA. The oculomotor integrator: testing of a neural network model. Exp Brain Res 1997; 113:57-74. The authors present a neural network for the ocular motor integrator that is biologically plausible. They test the model by comparing its predictions with the effects of lesions in monkey brainstem.
7. 7 Waespe W, Henn V. Neuronal activity in the vestibular nuclei of the alert monkey during vestibular and optokinetic stimulation. Exp Brain Res 1977; 27:523-538.
8. 8 Van Gisbergen JAM, Robinson DA, Gielen S. A quantitative analysis of the generation of saccadic eye movements by burst neurons. J Neurophysiol 1981; 45:417-442.
9. 9 Miles FA, Fuller J. Visual tracking and the primate flocculus. Science 1975; 189:1000-1002.
10. 10 Cannon SC, Robinson DA. Loss of the neural integrator of the oculomotor system from brain stem lesions in monkey. J Neurophysiol 1987; 57:1383-1409.
11. 11 Robinson DA. The effect of cerebellectomy on the cat's vestibulo-ocular integrator. Brain Res 1974; 71:195-207.
12. 12 Crawford JD, Cadera W, Vilis T. Generation of torsional and vertical eye position signals by the interstitial nucleus of Cajal. Science 1991; 252:1551-1553.
13. 13 Cheron G, Godaux E. Disabling of the oculomotor neural integrator by kainic acid injections in the prepositus-vestibular complex of the cat. J Physiol (Lond) 1987; 394:267-290.
14. 14 Mettens P, Godaux E, Cheron G, Galiana HL. Effect of muscimol microinjections into the prepositus hypoglossi and the medial vestibular nuclei on cat eye movements. J Neurophysiol 1994; 72:785-802.
15. 15 Straube A, Kurzan R, Büttner U. Differential effects of bicuculline and muscimol microinjections into the vestibular nuclei on simian eye movements. Exp Brain Res 1991; 86:347-358.
16. 16 Mettens P, Cheron G, Godaux E. NMDA receptors are involved in temporal integration in the oculomotor system of the cat. NeuroReport 1994; 5:1333-1336.
17. 17 Barton JJS, Sharpe JA. Oscillopsia and horizontal nystagmus with accelerating slow phases following lumbar puncture in the Arnold-Chiari malformation. Ann Neurol 1993; 33:418-421.
18. 18 Kaneko CRS. Eye movement deficits after ibotenic acid lesions of the nucleus prepositus hypoglossi in monkeys. I. Saccades and fixation. J Neurophysiol 1997; 78:1753-1768. This report clarifies the effects of NPH lesions and also strengthens the case for a separate integrator for saccades.
19. 19 Helmchen C, Rambold H, Fuhry L, Büttner U. Deficits in vertical and torsional eye movements after uni- and bilateral muscimol inactivation of the interstitial nucleus of Cajal of the alert monkey. Exp Brain Res 1998; 119:436-452. This is a carefully conducted study of pharmacologic inactivation of the INC, which provides evidence for distributed integration of vertical eye movement signals. The effects of these inactivations are very pertinent to clinical neurologists.
20. 20 Optican LM. A field theory of saccade generation: temporal-to-spatial transform in the superior colliculus. Vision Res 1995; 35:3313-3320.
21. 21 Sparks DL, Mays LE. Spatial localization of saccade targets. I. Compensation for stimulation-induced perturbations in eye position. J Neurophysiol 1983; 49:45-63.
22. 22 Wurtz RH. Vision for the control of eye movement. Invest Ophthalmol Vis Sci 1997; 37:2131-2145. A most readable summary of the important contributions that Dr Wurtz and coworkers have made to understanding how the superior colliculus controls saccades to visual targets.
23. 23 Aizawa H, Wurtz RH. Reversible inactivation of monkey superior colliculus. I. Curvature of saccadic trajectory. J Neurophysiol 1998; 79:2082-2096. This report summarizes the effects of inactivating the build-up layer of the superior colliculus. No saccadic hypermetria was produced, indicating that the superior colliculus does not contribute to integration of saccadic control signals.
24. •] by considering potential ways in which changed saccadic trajectory may be produced by inactivating the superior colliculus.
25. 25 Rottach KG, von Maydell RD, Das VE, Zivorofsky AZ, DiScenna AO, Gordon JL, et al. Evidence for independent feedback control of horizontal and vertical saccades from Niemann-Pick type C disease. Vision Res 1997; 37:3627-3638. This report tests cartesian versus polar models for saccade generation using oblique saccades made by normal subjects and by patients with Niemann-Pick type C disease.
26. 26 Lefèvre P, Quaia C, Optican LM. Distributed model of control of saccades by superior colliculus and cerebellum. Neural Networks 1998; 11:1175-1190.
27. 27 Kori AA, Das VE, Zivotofsky AZ, Leigh RJ. Memory-guided saccades: effects of cerebellar lesions. Vision Res 1998; 38:3181-3192 This study demonstrates that memory-guided saccades are inaccurate in patients with cerebellar disease, especially if the target moves during the memory period.
28. 28 Robinson FR, Straube A, Fuchs AF. Role of the caudal fastigial nucleus in saccade generation. II. Effects of muscimol inactivation. J Neurophysiol 1993; 70:1741-1758.
29. 29 Büttner-Ennever JA, Horn AKE. Pathways from cell groups of the paramedian tracts to the floccular region. Ann NY Acad Sci 1996; 781:532-540.
30. 30 Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997; 41:818-825. Gabapentin was shown to be an effective treatment for acquired pendular nystagmus in most patients studied, whereas baclofen was less effective.
31. 31 Starck M, Albrecht H, Straube A, Dieterich M. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 1997; 244:9-16. The drug memantine was shown to be effective in suppressing pendular nystagmus in this open-label trial.